Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-01

Clinical Trial Update: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update: a peginterferon treatment study for inactive chronic hepatitis B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginterferon (Pegylated interferon)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatitis B, Chronic | Phase 4 | Status: RECRUITING